Bioharvest Sciences (BHST) Cash & Current Investments (2023 - 2025)

Bioharvest Sciences' Cash & Current Investments history runs 3 years deep, the most recent figure standing at $23.0 million for Q4 2025.

• On a quarterly basis, Cash & Current Investments rose 733.94% year-over-year to $23.0 million in Q4 2025; TTM through Dec 2025 was $23.0 million, a 733.94% increase from a year earlier, with the FY2025 full-year figure at $23.0 million, up 733.94% from the prior year.
• Cash & Current Investments grew to $23.0 million in Q4 2025 per BHST's latest filing, from $11.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $23.0 million in Q4 2025 and bottomed at $2.8 million in Q1 2024.
• The 3-year median for Cash & Current Investments is $4.1 million (2025), against an average of $6.9 million.
• Across the five-year window, Cash & Current Investments slumped 50.11% in 2024 and jumped 733.94% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $5.5 million in 2023, then slumped by 50.11% to $2.8 million in 2024, then surged by 733.94% to $23.0 million in 2025.
• Per Business Quant, the three latest BHST Cash & Current Investments figures stand at $23.0 million (Q4 2025), $11.4 million (Q3 2025), and $4.1 million (Q2 2025).